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Abstract: Tumors in the lacrimal sac are rare yet important due to their malignant and potentially 
lethal outcomes if there is a misdiagnosis or delay in treatment. Epithelial tumors predominate 
with squamous cell carcinoma. We report a transitional cell carcinoma of the lacrimal sac and 
management course for the patient.
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Case report
A 58-year-old female presented with a six-month history of left-sided epiphora to the 
ophthalmologist. There were no associated symptoms of sinus disease including frontal 
headaches, rhinorrhea, postnasal drip, or nasal congestion. The patient’s vision had 
not changed during this period of time with visual acuity recorded as 6/6 in both eyes. 
There was no purulent or hemorrhagic discharge from the left tear duct. The patient 
had a history of hypertension, hyperlipidemia, and gastroesophageal reflux disease 
controlled by pharmacotherapy.
Examination revealed a painless swelling of the left lacrimal sac compared to the 
right. This had not been noticed by the patient previously. Probing and syringing of 
the left lacrimal system revealed obstruction. Oral antibiotics and lubricant eye drops 
were prescribed. With a preliminary diagnosis of dacryocystitis and nasolacrimal 
duct obstruction, a nasoendoscopic dacryocystorhinostomy was performed in 
January 2007.
During surgical exploration the lacrimal sac was documented to be swollen at 
20 mm in length. A mass lesion was suspected due to the increased size and change in 
consistency of the lacrimal sac. A mucosal biopsy was completed and a nasolacrimal 
tumor was suspected from the pathology. Surgical biopsies of the nasolacrimal sac 
are not routinely performed in dacryocystorhinostomy unless malignancy is suspected 
pre- or perioperatively. This mass was confirmed on the computed tomography scan 
postprimary dacryocystorhinostomy (Figure 1).
Planned revision surgery in March 2007 confirmed an infiltrative mass in the 
enlarged lacrimal sac. The lacrimal sac did not significantly increase in size during 
the two-month interval between primary dacryocystorhinostomy and revision surgery. 
Removal of the left lacrimal sac, nasolacrimal duct, and canaliculi were performed 
using both nasoendoscopic and external approaches (Figure 2). The entire lacrimal 
apparatus including the two upper and lower lid canaliculi, lacrimal sac and duct was 
resected intact and the gross specimen sent for histopathology (Figure 3).Clinical Ophthalmology 2009:3 588
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A reconstruction with island and rotational flap was 
performed to achieve full closure and the desired cosmetic 
effect. Associated functional endoscopic sinus surgery 
(FESS), septoplasty, and medial maxillectomy was performed 
by the otolaryngologist.
Histopathology
The nasolacrimal sac was lined by a malignant papillary 
epithelial tumor with distinct features of transitional 
cell carcinoma with focal squamous differentiation 
(nonkeratinizing cell carcinoma). The tumor was mostly 
noninvasive with isolated foci of stromal invasion. 
This high grade in situ carcinoma extended superiorly 
along both lacrimal canaliculi and inferiorly along the 
nasolacrimal duct. All margins were clear with appearance 
of complete excision (Figures 4–6).
Follow up
At postoperative day 10, the patient noted a satisfactory 
cosmetic effect (Figures 7, 8). No radiotherapy was given 
postoperatively. An ophthalmology review in August 
2007 revealed persistent left-sided epiphora, but no other 
associated symptoms. Further opening of the left punctum 
with probe under local anesthetic was required in August 
2007. This was attributed to postoperative scarring and the 
patient’s epiphora resolved. New nasal polyps were found 
in both maxillary sinus with removal and revision maxil-
lary FESS performed in November 2007. The polyps were 
diagnosed at a routine six-month check up with no symptoms 
experienced by the patient.
Figure 1 Computed tomography of the coronal view demonstrating the 
blockage of the ostiomeatal complex.   A medial mass lesion at the lacrimal sac is 
noted.   A bony osteium in the lacrimal bone is apparent from the first initial external 
dacryocystorhinostomy providing patency into the nasolacrimal duct.
Figure 2 Nasoendoscopic view of bony nasal lacrimal canal.   The canal is formed by 
the maxilla, the lacrimal bone and the inferior nasal concha.
Figure 3 Gross specimen postsurgical resection of lacrimal apparatus. Upper and 
lower lid canaliculi are visible with probes in situ. The lacrimal sac and duct was 
resected intact and the gross specimen sent for histopathology.Clinical Ophthalmology 2009:3 589
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the medical literature. Parmar and Rose described three 
cases of transitional cell carcinoma and one case of mixed 
transitional cell carcinoma and squamous cell carcinoma.1 
Ni and colleagues reviewed 82 patients with tumors of the 
nasolacrimal sac and found only six cases of transitional 
cell carcinoma.2 Stefanyszyn and colleagues documented 
only five transitional cells carcinomas out of 115 lacrimal 
sac tumors.3
The lacrimal sac is situated in the lacrimal fossa 
surrounded by lacrimal bone and the frontal process of the 
maxilla.4 As the sac is hidden within the anterior part of the 
medial wall of the orbit, tumors are hard to detect until there is 
functional blockage of the nasolacrimal duct or a mass effect 
noted. Tumors thus have a more insidious presentation with 
common symptoms of dacryocystitis and nasolacrimal duct 
obstruction. Epiphora may or may not be present. Patients may 
occasionally notice facial asymmetry and a painless swelling 
at the medial canthus. Hornblass and colleagues5 described a 
possible anatomical increased suspicion of malignancy with 
masses superior to the medial canthal tendon. Masses inferior 
to the medial canthus were more likely to be an inflammatory 
reaction. Suspicion of tumor is common at time of surgical 
exploration during dacryocystorhinostomy surgery as was 
suspected in our case. Flanagan and colleagues revealed that 
43% of lacrimal sac tumors were found inadvertently at the 
time of dacryocystorhinostomy.6 Anderson and colleagues 
reviewed 377 specimens and found that neoplasms resulting 
in chronic nasolacrimal duct obstruction occurred in 4.6% 
of cases and were unsuspected before surgery in 2.1% of 
patients.7 Associated proptosis and hemorrhagic discharge 
Figure 4 Nasal lacrimal apparatus postfixation with formula for histopathology. Correct 
anatomical orientation.   The lacrimal sac measured about 20-mm long and connected 
to the inferior meatus of the nose by the nasolacrimal duct.   The direction of the duct 
is downward, backward and lateral is lodged in the bony nasolacrimal canal.
Figure 5 Hematoxylin and eosin stain with low power magnification of the 
nasolacrimal sac.   This was lined by a malignant papillary epithelial tumor.   The tumor 
was mostly noninvasive with isolated foci of stromal invasion.
The patient was noted to be symptom free in August 
2009. Continued follow-up will be pursued to monitor future 
recurrence rates (Figures 7, 8).
Discussion
Primary carcinomas of the lacrimal sac are rare with 
less than 30 transitional cell carcinomas described in 
Figure 6 Higher power magnification (hematoxylin and eosin stain x80). Distinct 
features of transitional cell carcinoma were noted on microscopy with focal squamous 
differentiation (nonkeratinising cell carcinoma) High grade in situ carcinoma extended 
superiorly along both lacrimal canaliculi and inferiorly along the nasolacrimal duct.    All 
margins were clear with appearance of complete excision.Clinical Ophthalmology 2009:3 590
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from the tear duct are symptoms with a higher index of 
suspicion for lacrimal sac tumors. They were found to be 
late signs by Stefanyszyn and Ni.2,3
The mean age of those afflicted with transitional cell 
carcinoma was 47–50 years, similar to other lacrimal sac 
tumors which mainly occur in the fourth to fifth decade of 
life. Benign transitional cell papillomas were found to occur 
earlier at the age of 40 years.2,3 Anderson and colleagues 
described a case of invasive transitional cell carcinoma of 
the lacrimal sac arising from an inverted papilloma in a 
36-year-old patient8 and Ni and colleagues confirmed one 
case of transitional cell carcinoma in a 20-year-old patient.2 
This highlights the possibility of malignancy in younger 
populations. There were no statistically significant differ-
ences in occurrence of transitional cell carcinoma between 
males and females.
Computed tomography and magnetic resonance imaging 
(MRI) scan is important to delineate tumor size and the extent 
of bony destruction. Callender and colleagues confirm that 
computer tomography is a useful tool for diagnosing lacrimal 
sac tumors and identification of tumor extension to surrounding 
structures.9 A mass lesion was seen on a computed tomography 
scan in our case. However, the computed tomography scan was 
only performed after initial dacryocystorhinostomy surgery 
when a suspicion of malignancy was raised.
Suspected lacrimal drainage system malignancy is 
confirmed by histopathology from biopsy or resection of the 
nasolacrimal apparatus. Most authors recommend a standard 
dacryocystorhinostomy approach to the lacrimal fossa with 
wide excision.2,3,5,10 The recommended procedure performed 
in our case was complete resection of the nasolacrimal sac, 
and both upper and lower canaliculi and nasolacrimal duct 
for complete clearance. Upper and lower ethmoidectomy and 
partial maxillectomy were also recommended for extending 
mass and satellite lesions.1–3,5 Adjuvant radiotherapy 
is recommended for unrecognized local extension and 
microscopic residual disease. Primary radiotherapy is not 
recommended with Ni and colleagues describing a five-year 
mortality rate of 43.7% in three cases.2
Transitional cell carcinomas have a poor prognosis. Ni 
and colleagues described remote metastasis with transitional 
cell carcinoma despite extensive resection.2 This may be 
attributed to a delay in diagnosis from late discovery of the 
malignancy. Ni and colleagues found 100% of transitional 
cell carcinomas reviewed resulted in death from recurrence.2 
Stefanyszyn and colleagues described five patients with 
transitional cell carcinoma with two displaying local 
recurrence and subsequent mortality.3 Despite extensive 
wide excision and radiotherapy, one patient died of lung 
metastasis four years after diagnosis.3 Preechawai and col-
leagues reviewed the literature and described one third of 
patients having recurrent disease with a 22% rate of distant 
metastasis to the lungs and esophagus.11 This high recurrence 
rate was described as being due to, in part, inadequate initial 
treatment and late detection. The overall mortality rate quoted 
by Preechawai and colleagues is 44%.11 Parmar and Rose 
described a similar mortality of 37.5% for all epithelial 
tumors despite reported wide surgical excision and radio-
therapy.1 Like other carcinomas, prognosis for these malig-
nancies is influenced by the size and local extension of the 
tumor and by the presence or absence of metastases. Tumor 
histology most likely influences prognosis. Out of the malig-
nant epithelial neoplasm, squamous cell carcinomas are the 
most common. There are only a small number of documented 
Figure 7 Ten days postoperative follow-up: satisfactory cosmetic result.
Figure 8 Ten days postoperative follow-up: satisfactory cosmetic result.Clinical Ophthalmology 2009:3
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cases of transitional cell carcinomas. Good prognostic factors 
in the histopathology include well differentiated cells with 
uniform columnar cell, rare mitotic figures, and an intact 
basement membrane. Poor prognosis occurs when tumor 
tissue displays marked pleomorphism, squamous metaplasia, 
numerous mitotis figures, and areas of stromal invasion on 
histopathology examination.10
Transitional cell carcinoma in the lacrimal sac is a rare 
yet important disease due to their malignant and potentially 
lethal outcomes especially if there is a misdiagnosis or 
delay in treatment. Diagnosis is difficult due to the hidden 
anatomical location of the nasolacrimal system. Symptoms 
related to pathology have an insidious onset and occur in 
chronic inflammatory conditions of the nasolacrimal system 
as well. One should have a high index of suspicion in patients 
presenting with chronic low grade dacryocystitis without 
purulent discharge and epiphora. Computed tomography 
should be employed in those suspected of a lacrimal sac tumor 
for visualization of tumor size and extension preoperatively. 
Wide excision of the whole nasolacrimal apparatus with asso-
ciated functional endoscopic sinus surgery is recommended 
with or without adjuvant radiotherapy. Longer term follow 
up and surveillance is essential as regional and distant metas-
tases are consistently documented in the medical literature 
during original resections.
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